Carmen Bozic
CIK 1790029 · EVP and CMO · last filed 2026-06-23
Carmen Bozic is an EVP and CMO who has filed 74 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for VRTX, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$29.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.1M across reported positions. 76 SEC filings were submitted jointly with VERTEX PHARMACEUTICALS INC / MA.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VRTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
50 NORTHERN AVENUE
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | EVP and CMO | 15,933 | $510.08 | $8.13M | -$29.72M | 52 | 2026-06-23 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | VRTX | Notice (144) | −596 | -$287.6K | EDGAR |
| 2026-06-23 | VRTX | Sell (S) | −1,020 | -$471.4K | EDGAR |
| 2026-06-18 | VRTX | Notice (144) | −1,020 | -$471.4K | EDGAR |
| 2026-06-17 | VRTX | Sell (S) | −4,062 | -$1.83M | EDGAR |
| 2026-06-15 | VRTX | Notice (144) | −4,062 | -$1.83M | EDGAR |
| 2026-06-09 | VRTX | Sell (S) | −1,745 | -$785.2K | EDGAR |
| 2026-06-05 | VRTX | Notice (144) | −1,745 | -$785.2K | EDGAR |
| 2026-06-02 | VRTX | Sell (S) | −1,974 | -$888.3K | EDGAR |
| 2026-05-29 | VRTX | Notice (144) | −1,974 | -$888.3K | EDGAR |
| 2026-05-19 | VRTX | Sell (S) | −1,354 | -$614.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.